Literature DB >> 6489934

Tilorone acts as a lysosomotropic agent in fibroblasts.

D K Gupta, V Gieselmann, A Hasilik, K von Figura.   

Abstract

Tilorone, an amphiphilic cationic compound with antiviral activity perturbed the lysosomal system. In cultured fibroblasts tilorone induced storage of sulfated glycosaminoglycans, enhanced secretion of precursor forms of lysosomal enzymes, inhibited intracellular proteolytic maturation of lysosomal enzymes, and inhibited receptor-mediated endocytosis of lysosomal enzymes. In isolated lysosomes tilorone was found to increase pH and to abolish the ATP-dependent acidification. These effects suggest that tilorone acts like a weak base that accumulates in acid compartments of the cells, raises the pH therein and interferes with lysosomal catabolic activity and with receptor-mediated transport of lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489934     DOI: 10.1515/bchm2.1984.365.2.859

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  10 in total

1.  Cultured corneal fibroblasts as a model system for the demonstration of drug-induced mucopolysaccharidosis.

Authors:  J Burmester; K Handrock; R Lüllmann-Rauch
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Experimental mucopolysaccharidosis: preservation and ultrastructural visualization of intralysosomal glycosaminoglycans by use of the cationic dyes cuprolinic blue and toluidine blue.

Authors:  R Lüllmann-Rauch
Journal:  Histochemistry       Date:  1989

3.  Keratopathy in rats after treatment with tilorone.

Authors:  R Lüllmann-Rauch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  Lysosomal storage of sulfated glycosaminoglycans in renal interstitial cells of rats treated with tilorone.

Authors:  R Lullmann-Rauch
Journal:  Cell Tissue Res       Date:  1987-12       Impact factor: 5.249

5.  Tilorone-induced lysosomal storage of glycosaminoglycans in cultured corneal fibroblasts: biochemical and physicochemical investigations.

Authors:  J Fischer
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

6.  Tilorone-induced lysosomal lesions: the bisbasic character of the drug is essential for its high potency to cause storage of sulphated glycosaminoglycans.

Authors:  J Fischer; L Hein; R Lüllmann-Rauch; B von Witzendorff
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

7.  Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms.

Authors:  Ana C Puhl; Ethan J Fritch; Thomas R Lane; Longping V Tse; Boyd L Yount; Carolina Q Sacramento; Natalia Fintelman-Rodrigues; Tatyana Almeida Tavella; Fabio Trindade Maranhão Costa; Stuart Weston; James Logue; Matthew Frieman; Lakshmanane Premkumar; Kenneth H Pearce; Brett L Hurst; Carolina Horta Andrade; James A Levi; Nicole J Johnson; Samantha C Kisthardt; Frank Scholle; Thiago Moreno L Souza; Nathaniel John Moorman; Ralph S Baric; Peter B Madrid; Sean Ekins
Journal:  ACS Omega       Date:  2021-03-10

8.  Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.

Authors:  Thomas R Lane; Christopher Massey; Jason E Comer; Manu Anantpadma; Joel S Freundlich; Robert A Davey; Peter B Madrid; Sean Ekins
Journal:  PLoS Negl Trop Dis       Date:  2019-11-21

9.  Tilorone-Dihydrochloride Protects against Rift Valley Fever Virus Infection and Disease in the Mouse Model.

Authors:  Kendra N Johnson; Birte Kalveram; Jennifer K Smith; Lihong Zhang; Terry Juelich; Colm Atkins; Tetsuro Ikegami; Alexander N Freiberg
Journal:  Microorganisms       Date:  2021-12-31

10.  Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.

Authors:  Sean Ekins; Thomas R Lane; Peter B Madrid
Journal:  Pharm Res       Date:  2020-03-25       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.